Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides

Science

Volumn 281, Issue 5382, 1998, Pages 1515-1518

  Song, Hong Jun ^a   Ming, Guo Li ^a   He, Zhigang ^b   Lehmann, Maxime ^c   McKerracher, Lisa ^c   Tessier Lavigne, Marc ^b   Poo, Mu Ming ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC GMP; CYCLIC NUCLEOTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GROWTH CONE; MOLECULAR DYNAMICS; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD NERVE CELL; XENOPUS;

ANIMALIA;

EID: 0032483342     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5382.1515     Document Type: Article

References (50)

1. R. Keynes and G. M. W. Cook, Cell 83, 161 (1995); M. Tessier-Lavigne and C. S. Goodman, Science 274, 1123 (1996).
2. R. Keynes and G. M. W. Cook, Cell 83, 161 (1995); M. Tessier-Lavigne and C. S. Goodman, Science 274, 1123 (1996).
3. M. Tessier-Lavigne, M. Placzek, A. G. Lumsden, J. Doss, T. M. Jessell, Nature 336, 775 (1988); N. Ishii, W. G. Wadsworth, B. D. Stern, J. G. Culotti, E. M. Hedgecock, Neuron 9, 873 (1992); T. Serafini et al., Cell 78, 409 (1994); T. E. Kennedy, T. Serafini, J. R. de la Torre, M. Tessier-Lavigne, ibid. p. 425; S. A. Colamarino and M. Tessier-Lavigne, ibid. 81, 621 (1995).
4. M. Tessier-Lavigne, M. Placzek, A. G. Lumsden, J. Doss, T. M. Jessell, Nature 336, 775 (1988); N. Ishii, W. G. Wadsworth, B. D. Stern, J. G. Culotti, E. M. Hedgecock, Neuron 9, 873 (1992); T. Serafini et al., Cell 78, 409 (1994); T. E. Kennedy, T. Serafini, J. R. de la Torre, M. Tessier-Lavigne, ibid. p. 425; S. A. Colamarino and M. Tessier-Lavigne, ibid. 81, 621 (1995).
5. M. Tessier-Lavigne, M. Placzek, A. G. Lumsden, J. Doss, T. M. Jessell, Nature 336, 775 (1988); N. Ishii, W. G. Wadsworth, B. D. Stern, J. G. Culotti, E. M. Hedgecock, Neuron 9, 873 (1992); T. Serafini et al., Cell 78, 409 (1994); T. E. Kennedy, T. Serafini, J. R. de la Torre, M. Tessier-Lavigne, ibid. p. 425; S. A. Colamarino and M. Tessier-Lavigne, ibid. 81, 621 (1995).
6. M. Tessier-Lavigne, M. Placzek, A. G. Lumsden, J. Doss, T. M. Jessell, Nature 336, 775 (1988); N. Ishii, W. G. Wadsworth, B. D. Stern, J. G. Culotti, E. M. Hedgecock, Neuron 9, 873 (1992); T. Serafini et al., Cell 78, 409 (1994); T. E. Kennedy, T. Serafini, J. R. de la Torre, M. Tessier-Lavigne, ibid. p. 425; S. A. Colamarino and M. Tessier-Lavigne, ibid. 81, 621 (1995).
7. M. Tessier-Lavigne, M. Placzek, A. G. Lumsden, J. Doss, T. M. Jessell, Nature 336, 775 (1988); N. Ishii, W. G. Wadsworth, B. D. Stern, J. G. Culotti, E. M. Hedgecock, Neuron 9, 873 (1992); T. Serafini et al., Cell 78, 409 (1994); T. E. Kennedy, T. Serafini, J. R. de la Torre, M. Tessier-Lavigne, ibid. p. 425; S. A. Colamarino and M. Tessier-Lavigne, ibid. 81, 621 (1995).
8. M. Hamelin, Y. Zhou, M.-W. Su, I. M. Scott, J. G. Culotti, Nature 364, 327 (1993).
9. H-j. Song, G-l. Hing, M-m. Poo, ibid. 388, 275 (1997).
10. G-l. Hing et al., Neuron 19, 1225 (1997).
11. Y. Luo, D. Raible, J. A. Raper, Cell 75, 217 (1993); A. L. Kolodkin, D. J. Matthes, C. S. Goodman, ibid. p. 1389; E. K. Messersmith et al., ibid. 81, 949 (1995); A. W. Puschel, R. H. Adams, H. Betz, Mol. Cell. Neurosci. 7, 419 (1996).
12. Y. Luo, D. Raible, J. A. Raper, Cell 75, 217 (1993); A. L. Kolodkin, D. J. Matthes, C. S. Goodman, ibid. p. 1389; E. K. Messersmith et al., ibid. 81, 949 (1995); A. W. Puschel, R. H. Adams, H. Betz, Mol. Cell. Neurosci. 7, 419 (1996).
13. Y. Luo, D. Raible, J. A. Raper, Cell 75, 217 (1993); A. L. Kolodkin, D. J. Matthes, C. S. Goodman, ibid. p. 1389; E. K. Messersmith et al., ibid. 81, 949 (1995); A. W. Puschel, R. H. Adams, H. Betz, Mol. Cell. Neurosci. 7, 419 (1996).
14. Y. Luo, D. Raible, J. A. Raper, Cell 75, 217 (1993); A. L. Kolodkin, D. J. Matthes, C. S. Goodman, ibid. p. 1389; E. K. Messersmith et al., ibid. 81, 949 (1995); A. W. Puschel, R. H. Adams, H. Betz, Mol. Cell. Neurosci. 7, 419 (1996).
15. O. Behar, J. A. Golden, H. Mashimo, F. J. Schoen, M. C. Fishman, Nature 383, 525 (1996); M. Taniguchi et al., Neuron 19, 519 (1997).
16. O. Behar, J. A. Golden, H. Mashimo, F. J. Schoen, M. C. Fishman, Nature 383, 525 (1996); M. Taniguchi et al., Neuron 19, 519 (1997).
17. 3-fold lower than that in the pipette [ A. M. Lohof, M. Quilian, Y. Dan, M-m. Poo, J. Neurosci. 12, 1253 (1992)],
18. 3-fold lower than that in the pipette [ A. M. Lohof, M. Quilian, Y. Dan, M-m. Poo, J. Neurosci. 12, 1253 (1992)],
19. No obvious collapse of Xenopus growth cones was observed even when a higher concentration of Sema III (up to 100 μg/ml in the pipette) was applied to cultured Xenopus spinal neurons. We have not examined whether a uniform concentration of Sema III causes collapse as it does for chick and rat growth cones.
20. M. A. Schwarzschild and R. E. Zigmond, J. Neurochem. 56, 400 (1991). Pharmacological agents were added to the culture medium at least 30 min before the gradient was applied and were present during the experiments. The final concentrations of pharmacological agents in the medium were listed.
21. E. Butt, M. van Bemmelen, L. Fischer, U. Walter, B. Jastorff, FEBS Lett. 263, 47 (1990).
22. M. S. Wolin, K. S. Wood, L. J. Ignarro, J. Biol. Chem. 257, 13312 (1982).
23. E. Southam and J. Garthwaite, Neurosci. Lett. 130, 107 (1991).
24. H. H. Wu, C. V. Williams, S. C. McLoon, Science 265, 1593 (1994); A. J. Roskams, D. S. Bredt, T. M. Dawson, G. V. Ronnett, Neuron 13, 289 (1994); S. M. Gibbs and J. W. Truman, ibid. 20, 83 (1998).
25. H. H. Wu, C. V. Williams, S. C. McLoon, Science 265, 1593 (1994); A. J. Roskams, D. S. Bredt, T. M. Dawson, G. V. Ronnett, Neuron 13, 289 (1994); S. M. Gibbs and J. W. Truman, ibid. 20, 83 (1998).
26. H. H. Wu, C. V. Williams, S. C. McLoon, Science 265, 1593 (1994); A. J. Roskams, D. S. Bredt, T. M. Dawson, G. V. Ronnett, Neuron 13, 289 (1994); S. M. Gibbs and J. W. Truman, ibid. 20, 83 (1998).
27. J. D. Rothermel and L. H. Parker Botelho, J. Biochem. 251, 757 (1988).
28. These Xenopus cultures contain spinal neurons sensitive to various neurotransmitters [J. L. Bixby and N. C. Spitzer, J. Physiol. London 353, 143 (1984)] and exhibiting a wide range of capacity in secreting acetylcholine [J. Evers, M. Laser, Y. A. Sun, Z. P. Xie, M-m. Poo, J. Neurosci. 9, 1523 (1989)]. The variability of turning responses observed within a population of these neurons (see Fig. 2) could be attributed to either the heterogeneity of neuronal types or variability in the cytoplasmic concentration of cyclic nucleotides or other signal transduction components.
29. These Xenopus cultures contain spinal neurons sensitive to various neurotransmitters [J. L. Bixby and N. C. Spitzer, J. Physiol. London 353, 143 (1984)] and exhibiting a wide range of capacity in secreting acetylcholine [J. Evers, M. Laser, Y. A. Sun, Z. P. Xie, M-m. Poo, J. Neurosci. 9, 1523 (1989)]. The variability of turning responses observed within a population of these neurons (see Fig. 2) could be attributed to either the heterogeneity of neuronal types or variability in the cytoplasmic concentration of cyclic nucleotides or other signal transduction components.
30. Z. He and M. Tessier-Lavigne, Cell 90, 739 (1997).
31. A. L. Kolodkin et al., ibid. p. 753.
32. H. Chen, A. Chedotal, Z. He, C. S. Goodman, M. Tessier-Lavigne, Neuron 19, 547 (1997).
33. The antibody to neuropilin-1(α-28) is directed against the ectodomain of rat neuropilin-1, purified on a protein A-agarose column as described in (17), and does not cross react with neuropilin-2 (19). Using α-28, we detected a putative Xenopus neuropilin by protein blotting. Interaction of α-28 with putative Xenopus neuropilin in cultured Xenopus spinal neurons was confirmed by immunostaining. For antibody blocking experiments, α-28 (20 μg/ml) was added 30 min before the onset of the gradient. During the turning assay, the concentration of α-28 was 5 μg/ ml.
34. DRG explants derived from embryonic day 14 rat embryos were cultured with NGF (25 ng/ml) on plates precoated with poly-D-lysine and laminin for 20 hours before experiments as described in (17). Pharmacological agents were added an hour before the collapse assay. The collapse assay was performed on sensory axons from these explants with Sema III-Ap-containing medium essentially as described in (77). For visualization, growth cones were stained with rhodamine-phalloidin and then washed and mounted.
35. G. Mukhopadhyay, P. Doherty, F. S. Walsh, P. R. Crocker, M. T. Filbin, Neuron 13, 757 (1994); L. McKerracher et al., ibid. p. 805; M. Schafer, M. Fruttiger, D. Montag, M. Schachner, R. Martini, ibid. 16, 1107 (1996).
36. G. Mukhopadhyay, P. Doherty, F. S. Walsh, P. R. Crocker, M. T. Filbin, Neuron 13, 757 (1994); L. McKerracher et al., ibid. p. 805; M. Schafer, M. Fruttiger, D. Montag, M. Schachner, R. Martini, ibid. 16, 1107 (1996).
37. G. Mukhopadhyay, P. Doherty, F. S. Walsh, P. R. Crocker, M. T. Filbin, Neuron 13, 757 (1994); L. McKerracher et al., ibid. p. 805; M. Schafer, M. Fruttiger, D. Montag, M. Schachner, R. Martini, ibid. 16, 1107 (1996).
38. S. Sato, R. H. Quartes, R. O. Brady, W. W. Tourtellotte, Ann. Neurol. 15, 264 (1984); S. Tang et al., Mol. Cell Neurosci. 9, 333 (1997).
39. S. Sato, R. H. Quartes, R. O. Brady, W. W. Tourtellotte, Ann. Neurol. 15, 264 (1984); S. Tang et al., Mol. Cell Neurosci. 9, 333 (1997).
40. To generate rMAG, SF9 cells were infected with baculovirus expressing the extracellular domain of MAG and conditioned medium was collected 5 or 6 days after infection and purified as described [M. Li et al., J. Neurosci. Res. 46, 404 (1996)]. For experiments with inactivated rMAG, rMAG was heated at 80°C for 35 min.
41. S. B. Kater, M. P. Mattson, C. Cohan, J. A. Conner, Trends. Neurosci. 11, 317 (1988).
42. J. K. Ivins, J. A. Raper, R. N. Pittman, J. Neurosci. 11, 1597 (1991); C. E. Bandtlow, M. F. Schmidt, T. D. Hassinger, M. E. Schwab, S. B. Kater, Science 259, 80 (1993); J. Loschinger et al., J. Neurobiol. 33, 825 (1997).
43. J. K. Ivins, J. A. Raper, R. N. Pittman, J. Neurosci. 11, 1597 (1991); C. E. Bandtlow, M. F. Schmidt, T. D. Hassinger, M. E. Schwab, S. B. Kater, Science 259, 80 (1993); J. Loschinger et al., J. Neurobiol. 33, 825 (1997).
44. J. K. Ivins, J. A. Raper, R. N. Pittman, J. Neurosci. 11, 1597 (1991); C. E. Bandtlow, M. F. Schmidt, T. D. Hassinger, M. E. Schwab, S. B. Kater, Science 259, 80 (1993); J. Loschinger et al., J. Neurobiol. 33, 825 (1997).
45. J. R. Cooper, F. E. Bloom, R. H. Roth, The Biochemical Basis of Neuropharmacology (Oxford Univ. Press, New York, ed. 7, 1996); R. Laufer and J. Changeux, EMBO J. 6, 901 (1987); J. H. Fong and D. E. Ingber, Biochem. Biophys. Res. Commun. 221, 19 (1996).
46. J. R. Cooper, F. E. Bloom, R. H. Roth, The Biochemical Basis of Neuropharmacology (Oxford Univ. Press, New York, ed. 7, 1996); R. Laufer and J. Changeux, EMBO J. 6, 901 (1987); J. H. Fong and D. E. Ingber, Biochem. Biophys. Res. Commun. 221, 19 (1996).
47. J. R. Cooper, F. E. Bloom, R. H. Roth, The Biochemical Basis of Neuropharmacology (Oxford Univ. Press, New York, ed. 7, 1996); R. Laufer and J. Changeux, EMBO J. 6, 901 (1987); J. H. Fong and D. E. Ingber, Biochem. Biophys. Res. Commun. 221, 19 (1996).
48. Attraction of commissural axons toward the floor plate in the developing spinal cord might be switched off (or even converted to a repulsive response) after contact with the floor plate cells, allowing further axonal growth past the floor plate [R. Shirasaki, R. Katsumata, F. Murakami, Science 279, 105 (1998)].
49. M. E. Schwab and D. Bartholdi, Physiol. Rev. 76, 319 (1996).
50. We thank S. Faynboym for generating the netrin-1 protein. Supported by grants from NIH (NS22764 to M-m. P) and the American Paralysis Association and the International Spinal Research Trust (to M.T.-L). Z.H. is an Associate and M.T.-L is an Investigator of the Howard Hughes Medical Institute.